1
Method and device for vehicle stop and starting and position-lamps display. December 26, 2013: US20130345935-A1

A simple and effective control method is disclosed for starting and stopping vehicles engine and automatic lighting of position lamps to show the vehicles location, wherein an integration controller can be used to achieve those purpose. In particular, a useful control method is disclosed for stoppin ...


2
BRUSH HOLDER APPARATUS, BRUSH ASSEMBLY, AND METHOD. Cutsforth, December 26, 2013: US20130342073-A1

Devices and methods of use for brush holder assemblies are disclosed. Brush holder assemblies including a mounting block and a brush holder are disclosed. Also illustrated is a brush holder assembly including a first portion in sliding engagement with a second portion. In some embodiments the brush ...


3
NNMT AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). ROCHE DIAGNOSTICS OPERATIONS, December 26, 2013: US20130344504-A1

An in vitro method aiding in the assessment of chronic obstructive pulmonary disease (COPD). The disclosure further relates to a method for assessing COPD from a sample, derived from an individual, by measuring the protein NNMT in said sample in vitro.


4
APEX1 AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). ROCHE DIAGNOSTICS OPERATIONS, December 26, 2013: US20130344505-A1

An in vitro method aiding in the assessment of chronic obstructive pulmonary disease (COPD). The disclosure further relates to a method for assessing COPD from a sample, derived from an individual, by measuring the protein APEX1 in said sample in vitro.


5
SEPRASE AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). ROCHE DIAGNOSTICS OPERATIONS, December 26, 2013: US20130344506-A1

An in vitro method aiding in the assessment of chronic obstructive pulmonary disease (COPD). The disclosure further relates to a method for assessing COPD from a sample, derived from an individual, by measuring the protein Seprase in said sample in vitro.


6
ARMET AS A MARKER FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). ROCHE DIAGNOSTICS OPERATIONS, December 26, 2013: US20130344516-A1

An in vitro method aiding in the assessment of chronic obstructive pulmonary disease (COPD). The disclosure further relates to a method for assessing COPD from a sample, derived from an individual, by measuring the protein ARMET in said sample in vitro.


7
INDOOR LOCALIZATION USING COMMERCIAL FREQUENCY-MODULATED SIGNALS. Microsoft Corporation, December 26, 2013: US20130344892-A1

A commercial frequency-modulated (FM) radio signal indoor localization system and method for finding a location of a mobile embedded device (such as a smartphone) within a building. Indoor localization is performed by receiving commercial FM radio signals on the device, analyzing the signals using s ...


8
AUTOMATED STORAGE AND HANDLING SYSTEMS. December 26, 2013: US20130343843-A1

Automated handling systems move container through storage facilities with transfer elements that move to storage spaces, to an elevator, a margin space, and/or to a loading/unloading point. Different assemblies, arms, and structures are useable in these areas, including multiple arms and assemblies ...


9
ENRICHMENT OF NUCLEIC ACID TARGETS. BOREAL GENOMICS, December 26, 2013: US20130344498-A1

Methods and apparatus providing improved fidelity and specificity when separating nucleic acids from a sample, but without need for amplification. In particular, using the disclosed methods, it is possible to isolate a variant nucleic acid (i.e., a mutation) from a non-target nucleic acid (i.e., a w ...


10
PEG-MODIFIED ARGININE/LYSINE OXIDOREDUCTASE. December 26, 2013: US20130344052-A1

The present invention is directed to an arginine/lysine oxidoreductase modified with polyethylene glycol, a production method thereof, and methods of treating disorders responsive to a modification of amino acid levels reactive oxygen species and/or ammonium.